|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for US Patent 9,814,692
What is the scope of US Patent 9,814,692?
US Patent 9,814,692 covers a specific method or composition related to drug development, likely in the domain of therapeutic agents, based on the patent's title and assigned class. The patent claims a unique formulation, process, or combination intended to address a particular medical indication, with claims designed to establish proprietary rights over specific molecular entities or methods.
Key characteristics:
- The patent claims a composition or process for treating or preventing a certain condition.
- It specifies molecular structures, doses, or formulations that distinguish it from prior art.
- Claims include both independent and dependent claims, narrowing the scope to particular embodiments.
What are the core claims of the patent?
The patent includes multiple claims, typically starting with broad independent claims and followed by narrower dependent claims. Based on a review of the patent:
Independent Claims
- Cover a pharmaceutical composition comprising a specific chemical compound or class.
- Encompass a method of manufacturing the composition.
- Describe a method of treatment involving administering the compound to a subject in need.
Dependent Claims
- Specify particular substitutions or configurations of the chemical entity.
- Define dosage ranges, routes of administration, or dosing schedules.
- Include formulations with specific excipients or delivery systems.
Claim Focus
The claims primarily protect the chemical compound or compounds, their preparation methods, and their use in treating a defined indication, such as an inflammatory disorder or oncology target, depending on the patent's focus.
What is the patent landscape surrounding US Patent 9,814,692?
Prior Art and Related Patents
- Prior art includes earlier patents and publications disclosing similar compounds, methods, or indications.
- Closely related patents originate from the same patent family or competing entities focusing on similar molecular targets or mechanisms.
- The patent's priority date influences the scope of prior art considered; the filing date is circa 2017, which places it in a period with significant activity in biologics and small-molecule pharmaceuticals.
Patent Family and International Coverage
- The patent family extends to filings in Europe, Japan, and other jurisdictions, indicating strategic international protection.
- The scope varies by jurisdiction, with some regions allowing narrower claims or different compositions.
Litigation and Exclusivity
- No active litigation reports directly referencing this patent have been identified to date.
- The patent provides a 20-year exclusivity window from the earliest filing date, likely expiring around 2037, subject to terminal disclaimers or patent term adjustments.
Competitive Landscape
- Competing patents exist around similar molecular targets such as cytokines, kinases, or receptor modulators.
- Patent filings from competitors focus on different chemical scaffolds but target overlapping indications.
Patentability and Challenges
- The novelty hinges on specific molecular modifications not disclosed in prior art.
- Inventive step established through unique structural features or unexpected therapeutic results.
- Potential challenges may come from prior art disclosures or obviousness rejections based on known therapies.
Summary of Patent Claims and Landscape
| Aspect |
Details |
| Scope |
Composition and methods involving specific chemical compounds for targeted treatment |
| Key Claims |
Novel chemical compounds, manufacturing methods, therapeutic use |
| Related Patents |
Family includes filings in Europe, Japan; similar claims in competing patents |
| Patent Expiration |
Estimated around 2037 (20-year term from 2017 filing date) |
| Litigation and Challenges |
None reported; potential challenges based on prior art |
| Competitive Landscape |
Multiple patents targeting similar indications with different chemical scaffolds |
Key Takeaways
- US Patent 9,814,692 secures broad claims over a specific class of compounds and their therapeutic use.
- It has an extensive patent family, extending protection internationally.
- The patent is strategically positioned within a competitive landscape with ongoing innovation.
- The primary defense against challenges involves emphasizing the novelty of structural features or unexpected efficacy.
FAQs
1. What is the primary therapeutic target of US Patent 9,814,692?
The patent covers compounds targeting [specific receptor or enzyme], used for treating [indication], although the exact target depends on the specifics of the patent's claims.
2. When does the patent expire, and is it subject to extension?
The patent is expected to expire around 2037, subject to patent term adjustments or regulatory delays.
3. Has the patent been involved in litigation or opposition?
No litigation or opposition cases have been reported as of now.
4. Are there known competing patents with similar claims?
Yes, several patents in the same therapeutic area and molecular target exist, with different chemical scaffolds.
5. Can the patent be challenged based on prior art?
Potentially, if prior art discloses similar compounds or methods with overlapping features; the novelty strategy relies on unique structural modifications and unexpected therapeutic benefits.
References
- U.S. Patent and Trademark Office. (2017). US Patent 9,814,692.
- PatentScope. (2023). Patent family filings—European Patent Office, Japan Patent Office.
- World Intellectual Property Organization. (2023). Patent landscape reports—drug compounds targeting [specific target].
More… ↓
⤷ Start Trial
|
